Peripheral neuropathy in chronic respiratory insufficiency

Area of Science:

• Neurology
• Pulmonology
• Clinical Medicine

Background:

• Peripheral neuropathy is a frequent complication in patients diagnosed with chronic obstructive lung disease (COPD).
• The specific characteristics and prevalence of neuropathy in COPD require further elucidation.

Purpose of the Study:

• To investigate the prevalence and characteristics of peripheral neuropathy in patients with COPD.
• To explore the relationship between peripheral neuropathy and clinical parameters in COPD patients.

Main Methods:

• Neurophysiological studies, including assessment of compound muscle action potentials (CMAP) and sensory action potentials (SAP), were conducted.
• Patients were evaluated for clinical signs of motor and sensory polyneuropathy.
• Correlation analysis was performed between peripheral nervous system involvement and clinical factors such as hypercapnia, disability, hypoxia, age, and disease duration.

Main Results:

• Peripheral neuropathy was identified in 63.3% of the 30 COPD patients studied.
• The neuropathy was characterized as axonal polyneuropathy, with low amplitude CMAPs and SAPs and minimal reduction in nerve conduction velocity.
• Neuropathy severity correlated with hypercapnia and COPD severity, but not with hypoxia, age, or disease duration.
• Improvement in respiratory function led to progressive amelioration of neurological symptoms and neurophysiological parameters over one year.

Conclusions:

• A significant proportion of COPD patients exhibit peripheral neuropathy, primarily axonal polyneuropathy.
• Hypercapnia and COPD severity are associated with peripheral neuropathy in these patients.
• Therapeutic interventions aimed at improving respiratory function may positively impact neurological outcomes in COPD patients with peripheral neuropathy.